Similar Papers

Paper Title
Journal
Date
Author
Association between Patient-Reported Outcomes and Physical Activity Measured on the Apple Watch in Patients with Hematological Malignancies
Carrie A Thompson ... Kathleen Yost
Blood | VOL. 130
Carrie A Thompson, et. al.Carrie A Thompson ... Kathleen Yost
25 Jun 2021
225 SpineTrak: The First Randomized Controlled Trial Using the Apple Watch to Objectively Track Spine Surgical Patients
Megan Tang ... Christy Tomkins-Lane
Neurosurgery | VOL. 70
Megan Tang, et. al.Megan Tang ... Christy Tomkins-Lane
01 Apr 2024
P061 - Reduction in extraintestinal manifestations of Crohn's disease is associated with improvements in patient-reported and disease activity outcomes in patients treated with adalimumab
W Reinisch ... J Chao
Journal of Crohn's and Colitis | VOL. 3
W Reinisch, et. al.W Reinisch ... J Chao
30 Jan 2009
324 SpineTrak: The First Randomized Control Trial Using the Apple Watch to Objectively Track Spine Surgical Patients
Christopher Leung ... Christy Tompkins-Lane
Neurosurgery | VOL. 69
Christopher Leung, et. al.Christopher Leung ... Christy Tompkins-Lane
01 Apr 2023
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Rethinking the Path to Bladder Cancer Staging: Can Magnetic Resonance Imaging Speed Up Time to Receipt of Therapy in Patients With Muscle-Invasive Bladder Cancer?
Ashish M Kamat ... Paul Frankel
Journal of Clinical Oncology | VOL. -
Ashish M Kamat, et. al.Ashish M Kamat ... Paul Frankel
05 Feb 2025
Combined Analyses of Circulating Tumor DNA and Immunoscore in Patients With Stage III Colon Cancer: A Post Hoc Analysis of the PRODIGE-GERCOR IDEA-France/HORG-IDEA-Greece Trials
Julien Taieb ... Pierre Laurent-Puig
Journal of Clinical Oncology | VOL. -
Julien Taieb, et. al.Julien Taieb ... Pierre Laurent-Puig
04 Feb 2025
Aiming Targeted Drug Development at Rare Pediatric Malignancies
Julia L Glade Bender
Journal of Clinical Oncology | VOL. -
Julia L Glade BenderJulia L Glade Bender
03 Feb 2025
Updated results from the phase Ib/II study of fruquintinib combined with SOX and toripalimab in patients with advanced metastatic gastric/gastroesophageal junction adenocarcinoma (GC/GEJC).
Xiangrui Meng ... Lulu Guan
Journal of Clinical Oncology | VOL. 43
Xiangrui Meng, et. al.Xiangrui Meng ... Lulu Guan
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.